TotalMarketCap

Ligand Pharmaceuticals

LGNDNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$5.953 B

$297.63 -5.85%

Close of 6 Nov 2026

As of 6 Nov 2026, Ligand Pharmaceuticals (LGND) has a market capitalization of $5.95B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$268.1M

#2168 by revenue

Earnings

$124.5M

#1206 by earnings

Shares outstanding

20,002,986

Latest filing cover page

P/E ratio

47.8

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #47Ionis PharmaceuticalsIONS$6.43B
  2. #48Mirum PharmaceuticalsMIRM$6.11B
  3. #49Ligand PharmaceuticalsLGND$5.95B
  4. #50GrifolsGRFS$5.85B
  5. #51Belite BioBLTE$5.76B

What if Ligand Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,411,633

Per share 4,743× higher

Bitcoin $1.53T

$76,381.00

Per share 257× higher

Apple $5.02T

$250,751.69

Per share 842× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Ligand Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.